Periodic Change in Antibody titers against SARS-CoV-2 among COVID-19 positive patients: A Observational Cohort Study
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/01/030186
- Lead Sponsor
- Indian Council of Medical Research New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
The patients must be COVID-19 confirmed positive and having antibody developed after 21 days of detection. All patient will be tested for Antibody against SARS-CoV-2 before enrolment and those who have antibody will be enrolled.
Exclusion Criteria
The patients who havenâ??t developed antibody even after 21 days of detection will not to be enrolled for follow up in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anti SARS-CoV-2 IgG Antibodies are gradually waning with time among all the recovered COVID-19 positive patients.Timepoint: 16 weeks with a frequency of every fortnight.
- Secondary Outcome Measures
Name Time Method ot all the recovered COVID-19 patients are not developing antibodies.Timepoint: 16 weeks with a frequency of every fortnight.